Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
GlaxoSmithKline
GlaxoSmithKline
Page 3 of 5
Newsletters
GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug
By
Tech Reporter
December 18, 2019
Newsletters
One of Big Pharma’s Few Female CEOs May Be Joining Microsoft’s Board: Brainstorm Health
By
Trading Desk
September 20, 2019
Health
Can a Monthly Injection Treat HIV?—Brainstorm Health
By
Crypto Correspondent
July 8, 2019
Health
Glaxo Teams Up With CRISPR Pioneers From Berkeley, UCSF: Brainstorm Health
By
Tech Reporter
June 14, 2019
Health
Will Functional Genomics Cure Big Pharma’s Failure Rate?
By
Crypto Correspondent
April 9, 2019
Commentary
How New Tech From A.I. to Drones Is Improving Healthcare
By
Financial Writer
April 3, 2019
Tech
Data Sheet–How New Tech From A.I. to Drones is Improving Healthcare
By
Aaron Pressman
and
Adam Lashinsky
April 3, 2019
Glaxo to Split in Two Following Venture Deal with Pfizer
By
Tech Reporter
December 19, 2018
Health
Unilever In Exclusive Talks To Buy GSK’s Horlicks Unit
By
Industry Analyst
November 28, 2018
Features
Science ‘Mojo’ and an Executive Dream Team: CEO Emma Walmsley’s Bold Prescription for Reviving GlaxoSmithKline
By
Erika Fry
and
Claire Zillman
September 26, 2018
Health
GlaxoSmithKline Is Acquiring a $300 Million Stake in Genetic-Testing Company 23andMe
By
Tech Reporter
July 25, 2018
Health
There’s Massive Demand for GlaxoSmithKline’s Shingles Vaccine—And It’s Causing a Shortfall
By
Trading Desk
June 25, 2018
Leadership
GSK’s New CEO Emma Walmsley Has a Strong Start Out of the Gate
By
Crypto Correspondent
June 8, 2018
Health
GlaxoSmithKline Is Buying Out Novartis’s Share in Their Consumer Health Joint Venture
By
Blockchain Reporter
March 27, 2018
Health
PHOTOS: The Incredible Advances We’ve Made in the War Against HIV on World AIDS Day
By
Staff Writer
December 1, 2017
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Trading Desk
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Trading Desk
Economy
The analyst who once predicted the 'end of capitalism' sees Zohran Mamdani as a 'day of reckoning coming in'—and...
By
Editorial Team